Education
About Us
Working with TipRanks
Follow Us
Evolent Health (EVH)
NYSE:EVH
EVH Stock Chart & Stats
Day’s Range― - ―
52-Week Range$7.06 - $31.80
Previous CloseN/A
Volume268.11K
Average Volume (3M)3.14M
Market Cap
$1.06B
Enterprise Value$2.21B
Total Cash (Recent Filing)$151.00M
Total Debt (Recent Filing)$204.74M
Price to Earnings (P/E)―
Beta0.20
Next Earnings
Oct 29, 2025EPS Estimate
0.11Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.10
Shares Outstanding117,508,720
10 Day Avg. Volume1,824,705
30 Day Avg. Volume3,140,457
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap2.09
Enterprise Value/Revenue1.01
Enterprise Value/Gross Profit6.58
Enterprise Value/Ebitda209.48
Forecast
1Y Price Target
$15.64Price Target Upside73.39% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering13
Bulls Say, Bears Say
Bulls Say
Debt ManagementThe issuance of new 4.5% convertible notes allows Evolent to avoid over $9 million in annual interest expenses compared to using its committed term loan facility.
Earnings OutlookAnalysts maintain a BUY rating based on the expectation that Evolent can execute and meet conservative expectations, setting up a promising future.
Financial StrategyThe company's debt maturities have been pushed out to 2029, providing more breathing room to execute its strategies.
Bears Say
Quarterly EarningsEvolent Health reported somewhat mixed second quarter 2025 earnings, with revenue coming in toward the low end of guidance and modestly below the Street.
Revenue GuidanceRevenue guidance was lowered by $220M due to two PS delays, including a contract delay with AET.
Revenue PerformanceRevenue fell 8% quarter-over-quarter, missing expectations largely due to a delay in a PS contract.
Evolent Health News
EVH FAQ
What was Evolent Health’s price range in the past 12 months?
Evolent Health lowest stock price was $7.06 and its highest was $31.80 in the past 12 months.
What is Evolent Health’s market cap?
Evolent Health’s market cap is $1.06B.
When is Evolent Health’s upcoming earnings report date?
Evolent Health’s upcoming earnings report date is Oct 29, 2025 which is in 43 days.
How were Evolent Health’s earnings last quarter?
Evolent Health released its earnings results on Aug 07, 2025. The company reported -$0.1 earnings per share for the quarter, missing the consensus estimate of $0.074 by -$0.174.
Is Evolent Health overvalued?
According to Wall Street analysts Evolent Health’s price is currently Undervalued.
Does Evolent Health pay dividends?
Evolent Health does not currently pay dividends.
What is Evolent Health’s EPS estimate?
Evolent Health’s EPS estimate is 0.11.
How many shares outstanding does Evolent Health have?
Evolent Health has 117,508,720 shares outstanding.
What happened to Evolent Health’s price movement after its last earnings report?
Evolent Health reported an EPS of -$0.1 in its last earnings report, missing expectations of $0.074. Following the earnings report the stock price went down -7.121%.
Which hedge fund is a major shareholder of Evolent Health?
Currently, no hedge funds are holding shares in EVH
Evolent Health Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$15.64 (73.39% Upside)
$15.64 (73.39% Upside)
Blogger Sentiment
Neutral
EVH Sentiment 50%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Increased
By 2.0M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.0%
Last 30 Days ▼ 6.7%
Last 30 Days ▼ 6.7%
News Sentiment
Neutral
Bullish news 59%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-70.08%
12-Months-Change
Fundamentals
Return on Equity
-13.38%
Trailing 12-Months
Asset Growth
-0.55%
Trailing 12-Months
Company Description
Evolent Health
Evolent Health, Inc., a healthcare company, through its subsidiary, Evolent Health LLC, provides clinical and administrative solutions to payers and providers in the United States. It operates in two segments, Evolent Health Services and Clinical Solutions. The Evolent Health Services segment provides an integrated administrative and clinical platform for health plan administration and population health management. It offers financial and administrative management services, such as health plan services, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients, population health performance that delivers patient-centric cost-effective care. The Clinical Solutions segment offers specialty care management services support a range of specialty care delivery stakeholders during their transition from fee-for-service to value-based care, independent of their stage of maturation and specific market dynamics in oncology and cardiology; and holistic total cost of care improvement. The company was founded in 2011 and is headquartered in Arlington, Virginia.
EVH Company Deck
EVH Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
Evolent's earnings call reflects a strong performance in adjusted EBITDA and promising new partnerships, including a notable agreement with Aetna. Despite some challenges in revenue guidance and exchange business headwinds, the company's progress in AI and automation, along with a robust business pipeline, suggests a positive outlook.View all EVH earnings summariesEVH Stock 12 Month Forecast
Average Price Target
$15.64
▲(73.39% Upside)
Technical Analysis
Ownership Overview
2.20% Insiders
33.70% Mutual Funds
0.73% Other Institutional Investors
47.95% Public Companies and
Individual Investors